Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
-165K
-
Total reported value, excl. options
-
$14.1M
-
Value change
-
-$66.2K
-
Put/Call ratio
-
0.25
-
Number of buys
-
10
-
Number of sells
-
-21
-
Price
-
$0.88
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q4 2023
59 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q4 2023.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 129M outstanding shares and own 12.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.68M shares), BlackRock Inc. (2.8M shares), Laurion Capital Management LP (2.23M shares), RENAISSANCE TECHNOLOGIES LLC (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (1.11M shares), GSA CAPITAL PARTNERS LLP (449K shares), STATE STREET CORP (436K shares), BANK OF MONTREAL /CAN/ (353K shares), NORTHERN TRUST CORP (228K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (205K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.